FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 240 filers reported holding FATE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.68 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $330,857 | -40.6% | 58,045 | +5.1% | 0.01% | -47.6% |
Q4 2022 | $557,210 | -22.9% | 55,224 | +58.0% | 0.02% | -12.5% |
Q3 2022 | $723,000 | -18.4% | 34,950 | -2.3% | 0.02% | -11.1% |
Q2 2022 | $886,000 | +2.8% | 35,762 | +60.9% | 0.03% | +22.7% |
Q1 2022 | $862,000 | -20.4% | 22,222 | +20.1% | 0.02% | -21.4% |
Q4 2021 | $1,083,000 | +10.8% | 18,506 | +12.3% | 0.03% | -6.7% |
Q3 2021 | $977,000 | -36.3% | 16,483 | -6.7% | 0.03% | -36.2% |
Q2 2021 | $1,533,000 | +10.5% | 17,661 | +5.0% | 0.05% | 0.0% |
Q1 2021 | $1,387,000 | -9.7% | 16,820 | -0.4% | 0.05% | -25.4% |
Q4 2020 | $1,536,000 | -7.8% | 16,889 | -59.5% | 0.06% | -24.1% |
Q3 2020 | $1,666,000 | +8.9% | 41,670 | -6.5% | 0.08% | +3.8% |
Q2 2020 | $1,530,000 | -10.4% | 44,580 | -42.0% | 0.08% | -28.6% |
Q1 2020 | $1,708,000 | +6.8% | 76,894 | -5.9% | 0.11% | +13.1% |
Q4 2019 | $1,599,000 | +28.0% | 81,695 | +1.6% | 0.10% | -9.2% |
Q3 2019 | $1,249,000 | -25.6% | 80,421 | -2.8% | 0.11% | -19.3% |
Q2 2019 | $1,679,000 | -0.8% | 82,719 | -14.1% | 0.14% | +48.4% |
Q1 2019 | $1,692,000 | +32.2% | 96,315 | -3.5% | 0.09% | +26.4% |
Q4 2018 | $1,280,000 | -59.6% | 99,794 | -48.7% | 0.07% | -41.9% |
Q3 2018 | $3,172,000 | +34.7% | 194,700 | -6.2% | 0.12% | +33.3% |
Q2 2018 | $2,355,000 | – | 207,676 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JOHNSON & JOHNSON | 3,379,064 | $200,277,000 | 17.57% |
Redmile Group, LLC | 12,957,222 | $767,975,000 | 13.39% |
Copernicus Capital Management, LLC | 12,000 | $711,000 | 8.60% |
Grosvenor Holdings, L.L.C. | 1,037,256 | $61,478,000 | 7.53% |
DAFNA Capital Management LLC | 344,360 | $20,410,000 | 5.42% |
Casdin Capital, LLC | 3,400,000 | $201,518,000 | 5.02% |
Ally Bridge Group (NY) LLC | 270,000 | $16,003,000 | 4.70% |
Darwin Global Management, Ltd. | 353,250 | $20,937,000 | 3.85% |
Bellevue Group AG | 3,238,036 | $191,918,000 | 1.95% |
Artal Group S.A. | 1,450,000 | $85,942,000 | 1.92% |